Latest
simplywall.st Earnings
Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 1–36
- Headlines
- 131
- Sources here
- 13
- Companies here
- 13
Current section
Canada Drug Manufacturers - Specialty & Generic news
Chronological news
Latest headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Cardiol Therapeutics GAAP EPS of -C$0.05
* Cardiol Therapeutics press release [https://seekingalpha.com/filing/309942772] (CRDL:CA [https://seekingalpha.com/symbol/CRDL:CA]): Q2 GAAP EPS of -C$0.05. MORE ON CARDIOL THERAPEUTICS * Historical earnings data for Cardiol Therapeutics [https://seekingalpha.com/symbol/CRDL:CA/earnings] * Financial information for Cardiol Therapeutics [https://seekingalpha.com/symbol/CRDL:CA/income-statement]
CRDL
main company
Sharemaestro market context
Trend signal active
52 weeks +8.7% · Next-week setup negative 40.0%
Cronos (CRON) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman, President, and Chief Executive Officer - Michael Gorenstein Chief Financial Officer - Anna Shlimak Senior Director of Investor Relations and Corporate Development - Harrison Aaron Full Conference …
CRON
main company
Sharemaestro market context
Trend signal active
52 weeks +31.3% · Next-week setup negative 43.0%
Auxly Cannabis Group Inc Bottom Line Declines In Q2
(RTTNews) - Auxly Cannabis Group Inc (XLY.TO) announced a profit for second quarter that Dropped, from last year The company's earnings totaled $7.70 million, or $0.07 per share. This compares with $8.31 million, or $0.08 per share, last year. The company's revenue for the …
XLY
main company
Sharemaestro market context
Trend signal active
52 weeks +27.2% · Next-week setup negative 31.2%
Cipher Pharmaceuticals Reports Second Quarter 2026 Results
(All figures are presented in U.S. Dollars) Epuris® sales were $4.1 million during the quarter, a year-over-year increase of 14% compared to Q2 2025 and a sequential increase of 4% over Q1 2026 Letter of Intent executed with the pan-Canadian Pharmaceutical Alliance, securing expanded …
CPH
main company
Sharemaestro market context
Trend signal active
52 weeks +23.4%
DRI Healthcare Trust 2026 Q2 - Results - Earnings Call Presentation (TSX:DHT.UN:CA) 2026-08-11
Key Points Interested in DRI Healthcare Trust? Here are five stocks we like better. DRI Healthcare Trust reported record Q2 results: Total income rose 13% year over year to $50.1 million, cash receipts increased 16% to $46.5 million, and adjusted EBITDA climbed 40% to …
DHT-UN
main company
Sharemaestro market context
Trend signal active
52 weeks +27.2% · Next-week setup positive 55.8%
Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making?
Canopy Growth (NASDAQ: CGC) has spent the better part of the past five years destroying shareholder value. The stock is down more than 99% from its all-time high. The company has burned through billions of dollars, diluted shareholders repeatedly, exited non-core businesses, and cycled …
WEED
main company
Sharemaestro market context
Price below Trend Line
52 weeks -23.9% · Next-week setup negative 38.0%
DRI Healthcare Trust Q2 Earnings Call Highlights
Key Points Interested in DRI Healthcare Trust? Here are five stocks we like better. DRI Healthcare Trust reported record Q2 results: Total income rose 13% year over year to $50.1 million, cash receipts increased 16% to $46.5 million, and adjusted EBITDA climbed 40% to …
DHT-UN
main company
Sharemaestro market context
Trend signal active
52 weeks +27.2% · Next-week setup positive 55.8%